Literature DB >> 8422930

Role of a serum phospholipase A1 in the phosphatidylserine-induced T cell inhibition.

F Bellini1, A Bruni.   

Abstract

We have previously shown that unsaturated phosphatidylserines inhibit mitogen-induced T cell activation. We now report that the inhibitory action requires a protein present in bovine and human serum. Partial purification and phospholipase assay show that this protein has phospholipase A activity on phosphatidylserine but not phosphatidylethanolamine, phosphatidylcholine and phosphatidylinositol. In short incubations (1-3 h)2-acyl lysophosphatidylserine is produced but in longer incubations the cis-unsaturated fatty acid is also released. Experiments on peripheral blood mononuclear cells indicate that the unsaturated fatty acid becomes the main responsible for the PS-induced inhibition and that 2-acyl lysophosphatidylserine enhances the inhibitory effect of fatty acid.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8422930     DOI: 10.1016/0014-5793(93)81724-e

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

Review 1.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

2.  Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.

Authors:  Makoto Kurano; Kuniyuki Kano; Tomotaka Dohi; Hirotaka Matsumoto; Koji Igarashi; Masako Nishikawa; Ryunosuke Ohkawa; Hitoshi Ikeda; Katsumi Miyauchi; Hiroyuki Daida; Junken Aoki; Yutaka Yatomi
Journal:  J Lipid Res       Date:  2016-12-22       Impact factor: 5.922

3.  Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model.

Authors:  Fiona Y Glassman; Sathy V Balu-Iyer
Journal:  Int J Pharm       Date:  2018-07-05       Impact factor: 5.875

4.  Fueling the fire in the gut.

Authors:  Chia-Hao Lin; Li-Fan Lu
Journal:  J Exp Med       Date:  2022-05-27       Impact factor: 17.579

Review 5.  The Lysophosphatidylserines-An Emerging Class of Signalling Lysophospholipids.

Authors:  Karthik Shanbhag; Amol Mhetre; Neha Khandelwal; Siddhesh S Kamat
Journal:  J Membr Biol       Date:  2020-08-07       Impact factor: 1.843

Review 6.  Novel lysophosphoplipid receptors: their structure and function.

Authors:  Kumiko Makide; Akiharu Uwamizu; Yuji Shinjo; Jun Ishiguro; Michiyo Okutani; Asuka Inoue; Junken Aoki
Journal:  J Lipid Res       Date:  2014-06-02       Impact factor: 5.922

Review 7.  Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles.

Authors:  Fiona Y Glassman; Robert Dingman; Helena C Yau; Sathy V Balu-Iyer
Journal:  Immunol Invest       Date:  2020-03-23       Impact factor: 3.657

8.  Anti-inflammatory activity of salmeterol: down-regulation of cytokine production.

Authors:  L Sekut; B R Champion; K Page; J A Menius; K M Connolly
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

9.  The lysophosphatidylserine receptor GPR174 constrains regulatory T cell development and function.

Authors:  Michael J Barnes; Chien-Ming Li; Ying Xu; Jinping An; Yong Huang; Jason G Cyster
Journal:  J Exp Med       Date:  2015-06-15       Impact factor: 14.307

10.  Lysophosphatidylserine suppression of T-cell activation via GPR174 requires Gαs proteins.

Authors:  Michael J Barnes; Jason G Cyster
Journal:  Immunol Cell Biol       Date:  2018-03-25       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.